GMJ

Prof. Giorgi Pkhakadze, MD, MPH, PhD

MD, MPH, PhD. Editor-in-Chief, Georgian Medical Journal (GMJ). Professor and Head, School of Public Health, David Tvildiani Medical University (DTMU), Tbilisi, Georgia. Chair, Public Health Institute of Georgia (PHIG). President, Accréditation Sans Frontières (ASF), Paris. Secretary/Treasurer, UEMS Section of Public Health. WHO Consultant, Health and Migration, Geneva. Former Member, UN Secretary-General's Independent Accountability Panel for Every Woman, Every Child, Every Adolescent (IAP-EWEC, 2016–2021). ORCID: 0000-0001-7609-4515.
Follow:
1644 Articles

Botswana Becomes First Country to Achieve WHO Gold Tier Status for Eliminating Mother-to-Child HIV Transmission

Botswana becomes the first country globally to achieve WHO Gold Tier status for eliminating mother-to-child HIV transmission. The historic milestone…

Strong nurse-patient relationships reduce psychiatric hospital stays, UK study finds

New research shows that strong therapeutic relationships between psychiatric nurses and patients, formed within the first 48 hours of admission,…

One in Four Vulnerable Youth Experience Online Abuse, New Study Reveals

New research from the Child Mind Institute reveals that 25% of young people with mental health conditions experienced online abuse,…

Tomato-Soy Juice Blend Reduces Obesity-Related Inflammation in Clinical Trial

A clinical trial shows that a specially formulated tomato-soy juice reduced obesity-related inflammatory markers by up to 23% in just…

Autoimmune Disease Increases Risk of Poor Outcomes in Myelodysplastic Syndrome

New research published in Clinical Immunology establishes preexisting autoimmune disease as an independent risk factor for poor outcomes in myelodysplastic…

Cannabis Edibles and Alcohol Create Hidden Impairment Risk for Drivers, Johns Hopkins Study Reveals

New Johns Hopkins research reveals that combining cannabis edibles with alcohol increases driving impairment 2.8 times beyond alcohol alone. Standard…

Digital Twins of Donor Lungs Could Transform Transplant Medicine

Researchers create digital twins of donor lungs using ex vivo perfusion data, enabling virtual testing of therapies and personalized transplant…

Breakthrough Drug Shows 75% Response Rate in Hard-to-Treat Lung Cancer

Sunvozertinib achieved a 75% response rate in previously untreated lung cancer patients with EGFR exon 20 mutations, compared to 25%…

© 2026 GMJ News · PHIG · Sheni Network